Announcement on Progress in Using Certain Idle Raised Funds to Purchase Structured Deposits
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600529)"Shandong Pharmaceutical Glass Co., Ltd."Announcement on Progress in Using Certain Idle Raised Funds to Purchase Structured Deposits
Filed with SSE · Stock code 600529 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Shandong Pharmaceutical Glass Co., Ltd. on 6ix
Story so far
- (600529)"Shandong Pharmaceutical Glass Co., Ltd."Announcement on Redemption upon Maturity of Structured Deposits Purchased with Certain Idle Raised Funds
- Announcement on Receipt of the Review Inquiry Letter from the Shanghai Stock Exchange Regarding the Company's Application for Private Placement of Shares
- Announcement on Change of Sponsor Representative
Earlier from Shandong Pharmaceutical Glass
- (600529)"Shandong Pharmaceutical Glass Co., Ltd."Announcement on Redemption upon Maturity of Structured Deposits Purchased with Certain Idle Raised Funds
- (600529)"Shandong Pharmaceutical Glass Co., Ltd."Indicative Announcement on the Reply to the Review Inquiry Letter Regarding the Application Documents for the Private Placement of Shares and Updates of the Prospectus and Other Application Documents
- Announcement on Receipt of the Review Inquiry Letter from the Shanghai Stock Exchange Regarding the Company's Application for Private Placement of Shares
- Announcement on Change of Sponsor Representative
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
Follow Shandong Pharmaceutical Glass into a list and get an email when it puts out news.
Follow Shandong Pharmaceutical Glass